Xiamen Kingdomway Group posts strong H1 2025 profit surge

Xiamen Kingdomway Group reported a 90.12% increase in net profit attributable to shareholders, reaching 247,313,409.59 yuan for H1 2025, with total operating revenue climbing 13.46% to 1,728,484,797.27 yuan. This growth was attributed to the company's focus on innovation, cost reduction, and enhanced market positioning. The company also announced the establishment of Kingdomway E-Commerce LLC on February 24, 2025, and the deregistration of Xiamen Kingdomway Nutrition Foods Co., Ltd. on April 9, 2025.

Key operational highlights include a 126.38% increase in Vitamin A series sales volume and a 78.62% increase in production, recovering from a partial halt in 2024. Coenzyme Q10 series production rose 37.50%, leading to a 100.12% increase in year-end inventory. Additionally, Doctor's Best, Inc., a key subsidiary, saw its sales rise by 21.49% during the period.

The company's total assets grew by 7.59% to 6,877,375,206.26 yuan, and net assets attributable to shareholders increased by 1.15% to 4,329,961,137.84 yuan. No cash dividends, bonus shares, or capital increases from capital reserves are planned for the half-year.